Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;10(3):213-6.
doi: 10.3969/j.issn.1671-5411.2013.03.015.

Application of rotational atherectomy in the drug-eluting stent era

Chun-Chi Chen  1 , I-Chang Hsieh
Affiliations

Application of rotational atherectomy in the drug-eluting stent era

Chun-Chi Chen et al. J Geriatr Cardiol. 2013 Sep.

Abstract

Rotational atherectomy (RA) was introduced in the interventional arena in 1988 as a dedicated device for calcified lesions. Due to the complexity of the technique, the development of alternative methods such as the cutting balloon procedure, and the high restenosis rate of subsequent bare metal stenting in long lesions, its use had later declined. However, with the increasing use of drug-eluting stents (DES) and the aggressive treatment of longer lesions, the number of procedure performed with RA has increased significantly again in recent years. In this article, we reviewed the application of RA in DES era.

Keywords: Drug-eluting stents; Lesions; Rotational atherectomy.

PubMed Disclaimer

References

    1. Tan K, Sulke N, Taub N, et al. et al. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol. 1995;25:855–865. - PubMed
    1. Hoffmann R, Mintz GS, Popma JJ, et al. et al. Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J. 1998;19:1224–1231. - PubMed
    1. Moussa I, Ellis SG, Jones M, et al. et al. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV substudy) Am J Cardiol. 2005;96:1242–1247. - PubMed
    1. Berenguer A, Mainar V, Bordes P, et al. et al. Incidence and predictors of restenosis after sirolimus-eluting stent implantation in high-risk patients. Am Heart J. 2005;150:536–542. - PubMed
    1. Migliorini A, Shehu M, Carrabba N, et al. et al. Predictors of outcome after sirolimus- eluting stent implantation for complex in-stent restenosis. Am J Cardiol. 2005;96:1110–1112. - PubMed

LinkOut - more resources